Clinical correlates of serial urinary membrane attack complex estimates in patients with idiopathic membranous nephropathy

Clinical Nephrology

Volumn 60, Issue 1, 2003, Pages 7-12

  Cattran, Daniel C ^a   Wald, R ^a   Brenchley, P E C ^b   Coupes, B ^b   Ryan, N ^c   Ling, P ^c   Bartosik, L ^c   Rodhe, R ^c  

^a UNIVERSITY OF TORONTO   (Canada)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^c NONE

Author keywords

Focal segmental glomerulosclerosis; Idiopathic membranous nephropathy; Urinary membrane attack complex

Indexed keywords

COMPLEMENT MEMBRANE ATTACK COMPLEX; CREATININE; CYCLOSPORIN; PLACEBO; PREDNISONE; STEROID;

ADULT; AGE; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DEMOGRAPHY; DISEASE COURSE; DISEASE DURATION; DRUG RESPONSE; FOCAL GLOMERULOSCLEROSIS; GLOMERULOPATHY; GLOMERULUS FILTRATION; HISTOPATHOLOGY; HUMAN; IMMUNOMODULATION; KIDNEY FUNCTION; MEMBRANOUS GLOMERULONEPHRITIS; PATHOGENESIS; PREDICTION; PREVALENCE; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; URINARY EXCRETION;

ADULT; AGED; COMPLEMENT MEMBRANE ATTACK COMPLEX; CYCLOSPORINE; GLOMERULONEPHRITIS, MEMBRANOUS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MIDDLE AGED;

EID: 0037706983     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Abbate M, Zoja C, Corna D, Capitanio M, Bertani T, Remuzzi G 1998 In progressive nephropathies, overload of tubular cells with filtered proteins translates glomerular permeability dysfunction into cellular signals of interstitial inflammation. J Am Soc Nephrol 9: 1213-1224
2. Abbate M, Benigni A, Bertani T, Remuzzi G 1999 Nephrotoxicity of increased glomerular protein traffic. Nephrol Dial Transplat 14: 304-312
3. Biancone L, David S, Della Pietra V, Montrucchio G, Cambi V, Camussi G 1994 Alternative pathway activation of complement by cultured human proximal tubular epithelial cells. Kidney Int 45: 451-460
4. 3dg and C5b-9 indicate active immune disease in human membranous nephropathy. Kidney Int 41: 933-937
5. Cattran DC, Appel GB, Hebert LA, Hunsicker LG, Pohl MA, Hoy WE, Maxwell DR, Kunis CL for the North American Nephrotic Syndrome Study Group 1999 A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. Kidney Int 56: 2220-2226
6. Cattran DC, Appel GB, Hebert LA, Hunsicker LG, Pohl MA, Hoy WE, Maxwell DR, Kunis CL for the North American Nephrotic Syndrome Study Group 2001 Cyclosporine in patients with steroid resistant membranous nephropathy: a randomized trial. Kidney Int 59: 1484-1490
7. 3dg and clinical parameters in human membranous nephropathy. Nephrol Dial Transplant 8: 397-401
8. Couser WG, Schulze M, Pruchno CJ 1992 Role of C5b-9 in experimental membranous nephropathy. Nephrol Dial Transplant Suppl 1: 25-31
9. Cybulsky AV, Papillon J, McTavish AJ 1998 Complement activates phospholipases and protein kinases in glomerular epithelial cells. Kidney Int 54: 360-372
10. David S, Biancone L, Caserta C, Bussolati B, Cambi V, Camussi G 1997 Alternative pathway complement activation induces proinflammatory activity in human proximal tubular epithelial cells. Nephrol Dial Transplant 12: 51-56
11. Honkanen E, Teppo AM, Meri S, Lehto T, Gronhagen-Riska C 1994 Urinary excretion of cytokines and complement SC5b-9 in idiopathic membranous glomerulonephritis. Nephrol Dial Transplant 9: 1553-1559
12. Kerjaschki D, Schulze M, Binder S, Kain R, Ojha PP, Susani M, Horvat R, Baker PJ, Couser WG 1989 Transcellular transport and membrane insertion of the C5b-9 membrane attack complex of complement by glomerular epithelial cells in experimental membranous nephropathy. J Immunol 143: 546-552
13. Kon SP, Coupes B, Short CD, Solomon LR, Raftery MJ, Mallick NP, Brenchley PE 1995 Urinary C5b-9 excretion and clinical course in idiopathic human membranous nephropathy. Kidney Int 48: 1953-1958
14. Kusunoki Y, Akutsu Y, Itami N, Tochimaru H, Nagata Y, Takekoshi Y, Sagawa A, Kataoka Y, Nagasawa S 1991 Urinary excretion of terminal complement complexes in glomerular disease. Nephron 59: 27-32
15. Laluck BJ, Cattran DC 1999 Prognosis after a complete remission in adult patients with idiopathic membranous nephropathy. Am J Kidney Dis 33: 1026-1032
16. Leenaerts PL, Hall BM, Van Damme BJ, Daha MR, Vanrenterghem YF 1995 Active Heymann nephritis in complement C6 deficient rats. Kidney Int 47: 1604-1614
17. 3 synthesis in idiopathic membranous nephropathy: correlation to urinary C5b-9 excretion. Kidney Int 57: 137-146
18. Morita Y, Ikeguchi H, Nakamura J, Hotta N, Yuzawa Y, Matsuo S 2000 Complement activation products in the urine from proteinuric patients. J Am Soc Nephrol 11: 700-707
19. Ogrodowski JL, Hebert LA, Sedmak D, Cosio FG, Tamerius J, Kolb W 1991 Measurement of SC5b-9 in urine in patients with the nephrotic syndrome. Kidney Int 40: 1141-1147
20. Praga M, Artal EP, Hernandez E, Segura J, Moreno MA, Morales JM, Rodicio JL, 1997 Antiproteinuric effect of angiotensin-converting enzyme inhibition and C5b-9 urinary excretion in membranous glomerulonephritis. Nephrol Dial Transplant 12: 2576-2579
21. Ruggenenti P, Perna A, Mosconi L, Pisoni R, Remuzzi G and Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN) 1998 Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies. Kidney Int 53: 1209-1216
22. Salant DJ, Belok S, Madaio MP, Couser WG 1980 A new role for complement in experimental membranous nephropathy in rats. J Clin Invest 66: 1339-1350
23. Schulze M, Baker PJ, Perkinson DT, Johnson RJ, Ochi RF, Stahl RAK, Couser WG 1989 Increased urinary excretion of C5b-9 distinguishes passive Heymann nephritis in the rat. Kidney Int 35: 60-68
24. Schulze M, Donadio JV, Pruchno CJ, Baker PJ, Johnson RJ, Stahl RAK, Watkins S, Martin DC, Wurzner R, Gotze O, Couser WG 1991 Elevated urinary excretion of the C5b-9 complex in membranous nephropathy. Kidney Int 40: 533-538
25. Short CD, Mallick NP 1997 Membranous nephropathy. In: Schrier RW, Gottschalk CW (eds): Diseases of the kidney. Little, Brown and Company, Boston, 1693-1723